From TokenPost · · 50s
TL;DR: Vivos Targets $3.8 Million Revenue Lift
Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract talks by early 2027.
Vivos Therapeutics targets $3.8 million in additional annual revenue from payer contract renegotiations to achieve positive operating cash flow by early 2027. Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract talks by early 2027. Vivos Therapeutics aims to boost annual revenue by $3.8 million through payer contract renegotiations to achieve positive operating cash flow by early 2027.
- Vivos Therapeutics Revenue Target
- Financial Risks
- Nasdaq Listing Risk
Read the story version — the same reporting as a swipeable deck of 3 cards.






